1. 156P A phase Ib/II study of nanatinostat (Nstat) plus valganciclovir (VGCV) in advanced Epstein-Barr virus positive (EBV+) solid tumors and with pembrolizumab (PEM) in recurrent/metastatic nasopharyngeal carcinoma (RM-NPC). (December 2022) Authors: Colevas, A.D.; Siu, L.L.; Lim, D.W-T.; Gao, B.; Khan, S.A.; Eng, L.; Voon, P.J.; Ahn, M-J.; Elguindy, A.; Katkov, A.; Rojkjaer, L.; Katz, Y.; Ma, B.B.Y. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗